S100A4 and disease of the tendon: This evidence supports the suggestion that S100a4 acts as the upstream mediator of αSMA, even though S100a4 expression is lost during the transition from TDSCs to SCX+αSMA+ cells, with this increased expression of SCX+S100a4+ cells leading to fibrotic tendinopathies (Fig. 1iii).